Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 759,238 |
|
|||||
| News | - | ||||||
| Day High | 159.35 | Low High |
|||||
| Day Low | 152.19 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Repligen Corp | RGEN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -3.92 | -2.44% | 157.06 | 17:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 154.59 | 152.19 | 159.35 | 157.06 | 160.98 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 14,712 | 759,238 | $ 156.49 | $ 118,815,812 | - | 110.45 - 211.13 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:53:13 | 1 | $ 157.90 | USD |
Repligen (RGEN) Options Flow Summary
Repligen Corp Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.76B | 55.77M | - | 669.33M | 41.58M | 0.75 | 210.62 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Repligen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGEN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 175.35 | 176.875 | 152.19 | 167.41 | 518,260 | -18.29 | -10.43% |
| 1 Month | 196.58 | 200.23 | 152.19 | 177.47 | 445,372 | -39.52 | -20.10% |
| 3 Months | 183.71 | 211.13 | 152.19 | 190.73 | 518,599 | -26.65 | -14.51% |
| 6 Months | 144.42 | 211.13 | 110.45 | 170.58 | 603,435 | 12.64 | 8.75% |
| 1 Year | 174.11 | 211.13 | 110.45 | 165.41 | 589,713 | -17.05 | -9.79% |
| 3 Years | 213.00 | 327.32 | 110.45 | 186.86 | 518,405 | -55.94 | -26.26% |
| 5 Years | 54.14 | 327.32 | 52.87 | 161.03 | 507,675 | 102.92 | 190.10% |
Repligen Description
| Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America. |
